Keyphrases
Cancer-free
100%
Soluble Urokinase Plasminogen Activator Receptor (suPAR)
100%
Risk Markers
100%
Cancer Types
33%
Risk Factors
33%
In Cancer
22%
Leukocytes
22%
C-reactive Protein
22%
Gastrointestinal
22%
Inflammation
22%
Baseline Characteristics
11%
Commercially Available
11%
Prospective Cohort Study
11%
Incident Cancer
11%
Population-based
11%
Population-based Study
11%
Plasma Samples
11%
Gastrointestinal Cancer
11%
Cancer Risk
11%
Inflammatory Markers
11%
Follow-up Data
11%
Cox Regression
11%
Cardiovascular Disease
11%
Cancer Development
11%
International Classification of Diseases
11%
International Classification of Diseases-10
11%
Plasma Biomarkers
11%
Medicine and Dentistry
Urokinase Receptor
100%
Malignant Neoplasm
100%
Lung Cancer
100%
Biological Marker
22%
C Reactive Protein
22%
Population
22%
Leukocyte
22%
International Classification of Diseases
22%
Cancer Risk
11%
Prospective Study
11%
Cardiovascular Disease
11%
Proportional Hazards Model
11%
Diseases
11%
Gastrointestinal Cancer
11%
Cancer Types
11%
Enzyme Linked Immunosorbent Assay
11%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Lung Cancer
100%
Urokinase Receptor
100%
C Reactive Protein
22%
Inflammation
22%
Biological Marker
22%
Diseases
11%
Digestive System Cancer
11%
Cardiovascular Disease
11%
Enzyme-Linked Immunosorbent Assay
11%
Prospective Study
11%
Agricultural and Biological Sciences
Urokinase Receptor
100%
Blood Plasma
100%
Risk Factor
33%
C-Reactive Protein
22%
Population
22%
Leukocyte
22%
Cardiovascular System
11%
Immunology and Microbiology
Urokinase Receptor
100%
Blood Plasma
100%
C-Reactive Protein
22%
International Classification of Diseases
22%
Leukocyte
22%
Population
22%
ELISA
11%
Biochemistry, Genetics and Molecular Biology
Urokinase Receptor
100%
Blood Plasma
100%
C-Reactive Protein
22%
International Classification of Diseases
22%
Population
22%
Leukocyte
22%
Prospective Study
11%